Drug Discovery Chemistry Conference 2016

2016 Archived Content

OVERVIEW | DOWNLOAD BROCHURE | DISTINGUISHED FACULTY | SHORT COURSES

APRIL 19 - APRIL 20

Epigenetic Inhibitor Discovery

APRIL 20 - APRIL 21

Macrocyclics & Constrained Peptides

Biophysical Approaches for Drug Discovery

Antivirals: Small Molecule Inhibitors of Viral Targets

Applying Pharmacology to New Drug Discovery

2016 PLENARY KEYNOTES

Peter Schultz A Chemist's Foray into Translational Research

Peter G. Schultz, Ph.D., The Scripps Research Institute

Gregory Verdine Cell-Penetrating Miniproteins

Gregory L. Verdine, Ph.D., Harvard University

Sponsorship & Exhibit Opportunities

Participating as a sponsor or exhibitor provides excellent exposure and networking with more than 600 high-level decision makers!

Learn More

Record Attendance for Drug Discovery Chemistry 2016
600 participants from 25 countries gathered in beautiful San Diego for Cambridge Healthtech Institute’s Eleventh Annual Drug Discovery Chemistry conference. Focused on discovery and optimization challenges of small molecule drug candidates, this event once again provided many exciting opportunities for scientists to create a unique program according to personal interests by encouraging track-hopping between multiple synergistic conference tracks. 28% of attendees were from the pharmaceutical industry with an additional 44% from biotech and 16% from academia. 30% were titled as executive/director, 43% as scientist/technologist, and 9% as professor.

The 2016 event featured: